BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11378386)

  • 1. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.
    Patel L; Pass I; Coxon P; Downes CP; Smith SA; Macphee CH
    Curr Biol; 2001 May; 11(10):764-8. PubMed ID: 11378386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PPARgamma increases PTEN expression in pancreatic cancer cells.
    Farrow B; Evers BM
    Biochem Biophys Res Commun; 2003 Jan; 301(1):50-3. PubMed ID: 12535639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.
    Goetze S; Bungenstock A; Czupalla C; Eilers F; Stawowy P; Kintscher U; Spencer-Hänsch C; Graf K; Nürnberg B; Law RE; Fleck E; Gräfe M
    Hypertension; 2002 Nov; 40(5):748-54. PubMed ID: 12411472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation.
    Hong G; Davis B; Khatoon N; Baker SF; Brown J
    Biochem Biophys Res Commun; 2003 Apr; 303(3):782-7. PubMed ID: 12670479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling.
    Adamson DJ; Frew D; Tatoud R; Wolf CR; Palmer CN
    Mol Pharmacol; 2002 Jan; 61(1):7-12. PubMed ID: 11752200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
    Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
    Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone.
    Teresi RE; Shaiu CW; Chen CS; Chatterjee VK; Waite KA; Eng C
    Int J Cancer; 2006 May; 118(10):2390-8. PubMed ID: 16425225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
    To KKW; Wu WKK; Loong HHF
    Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
    Saubermann LJ; Nakajima A; Wada K; Zhao S; Terauchi Y; Kadowaki T; Aburatani H; Matsuhashi N; Nagai R; Blumberg RS
    Inflamm Bowel Dis; 2002 Sep; 8(5):330-9. PubMed ID: 12479648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404.
    Zhang W; Wu N; Li Z; Wang L; Jin J; Zha XL
    Cancer Biol Ther; 2006 Aug; 5(8):1008-14. PubMed ID: 16775433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
    Burgermeister E; Tencer L; Liscovitch M
    Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
    J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN.
    Lee KS; Park SJ; Hwang PH; Yi HK; Song CH; Chai OH; Kim JS; Lee MK; Lee YC
    FASEB J; 2005 Jun; 19(8):1033-5. PubMed ID: 15788448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
    Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
    J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
    Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
    Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.